Drug Patent Watch

DECEMBER 9, 2024

This patent was later revoked after the Indian government challenged it, citing ancient Ayurvedic texts that documented this use of turmeric. Taxol: From Pacific Yew to Cancer Treatment Taxol (paclitaxel), a widely used cancer drug, was originally isolated from the bark of the Pacific yew tree.

Drugs 97

Drugs Drug Development Pharmaceuticals Production 97

Drug Discovery Today

MAY 26, 2023

BARCELONA/LONDON, 25.05.23: Seqera Labs, the leading provider of secure workflow orchestration software in the life sciences sector, has partnered with Genomics England, the government-owned company that launched the 100,000 Genomes Project in partnership with the NHS.

Research 113

Research Government Science Treatment 113

Perficient: Drug Development

AUGUST 15, 2024

Social factors consider a company’s treatment of employees, diversity and inclusion practices, community relations, and involvement in socially responsible initiatives. Governance factors focus on the organization’s leadership, transparency, accountability, and adherence to ethical business practices.”

Government 52

Government Regulations Marketing International 52

The Pharma Data

NOVEMBER 23, 2020

Human genetic goods are tightly regulated by the Chinese government. Legend was launched to expand GenScript’s capabilities of developing a broad range of immunotherapy treatments. Food and Drug Administration last year and appears to be on track for a potential regulatory review as a treatment for multiple myeloma next year.

Government 52

Government Molecular Biology Regulations Laboratories 52

The Pharma Data

NOVEMBER 10, 2020

Antibody Treatment Approved for Emergency Use Against Early COVID-19. 10, 2020 — Eli Lilly’s experimental antibody treatment for COVID-19 was given emergency approval by the U.S. Instead, the treatment should be given as soon as possible after a positive test and within 10 days of developing symptoms. government.

Treatment 52

Treatment Government Hospitals FDA 52

The Pharma Data

AUGUST 31, 2020

Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate. Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate. MONTRÉAL, QC – August 31, 2020 – Janssen Inc.,

Government 52

Government Vaccine Pharmaceutical Companies Clinical Trials 52

The Pharma Data

JULY 15, 2021

– Victorian State Government extends financing of JJIPO@Monash for an additional two years. Johnson & Johnson Innovation announced today the extension of the Johnson & Johnson Innovation Partnering Office at Monash University’s Clayton Campus in Melbourne (JJIPO@Monash) in collaboration with the Victorian State Government.

Government 52

Government Science Pharmaceuticals Pharmaceutical Companies 52

Advarra

MARCH 6, 2025

For more than 35 years, Advarra has been committed to protecting the rights and welfare of clinical trial participants while helping to improve healthcare outcomes, advancing medical knowledge, and bringing innovative, life-extending treatments to market that benefit millions of patients worldwide.

Clinical Research 52

Clinical Research Research Clinical Trials Bioethics 52

The Premier Consulting Blog

NOVEMBER 6, 2024

Inhaled combination products (ICP) have emerged as a significant advancement in the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary conditions. What regulatory division governs ICPs? ICPs are subject to rigorous regulatory scrutiny due to their complexity.

Production 52

Production FDA Compliance Disease 52

ASPET

JUNE 30, 2023

It was found that combining these drugs with lower doses and for shorter treatment periods induced greater or equal toxicity in cancer cells than using either as a single agent. Here, we develop a mathematical model to investigate the effects of ceralasertib and olaparib, two drugs that target DNA damage response pathways.

DNA 100

DNA Therapies Government Treatment 100

SCIENMAG: Medicine & Health

JULY 11, 2023

Reducing the burden of Sickle Cell Disease (SCD) requires substantial financial and political commitment to improving data-collection, diagnosis, treatment and training – doing so will positively impact the lives of millions of patients and families […]

Disease 78

Disease Government Treatment 78

Drug Target Review

NOVEMBER 3, 2023

She continued: “By doing this, we aimed to uncover the intricate signalling system that directs cells down their predetermined routes, in the same way that traffic lights govern the movement of vehicles in a busy city.” This is like switching the ‘traffic lights’ on or off.”

Research 111

Research Regulations DNA Government 111

The Pharma Data

AUGUST 5, 2020

Government for 100 Million Doses of Investigational COVID-19 Vaccine. Government for 100 Million Doses of Investigational COVID-19 Vaccine. government for the large scale domestic manufacturing and delivery in the U.S. government may also purchase an additional 200 million doses of Ad26.COV2.S New Brunswick, N.J.,

Government 52

Government Vaccine Pharmaceutical Companies Pharmaceuticals 52

PPD

OCTOBER 17, 2024

In China, the high incidence of solid tumors is driving an urgent need for advanced therapies, spurring the push for new treatment approaches. There has also been an increase in government and regulatory support for CGT trials, in conjunction with an increase in investments for these products to get to market.

Therapies 97

Therapies Clinical Trials Clinical Research Trials 97

The Pharma Data

JULY 23, 2021

government has purchased an additional 200 million doses of the Pfizer-BioNTech COVID-19 Vaccine. government under its existing supply agreement to 500 million. government with 500 million doses of the companies’ COVID-19 vaccine for donation to the world’s poorest nations. This press release features multimedia. Eligible U.S.

Vaccine 52

Vaccine Government Immune Response FDA 52

The Pharma Data

OCTOBER 30, 2020

More recently, the FDA announced regulatory approval for the first treatment for Covid-19. FDA approves first treatment for Covid-19. On October 22, the FDA approved the antiviral drug Veklury for use in adult and pediatric patients for the treatment of Covid-19 requiring hospitalization.

FDA Approval 52

FDA Approval Vaccine FDA Treatment 52

The Pharma Data

APRIL 4, 2022

The high rate of unvaccinated people will continue to put a strain on hospitals and healthcare systems around the world, furthering the need for effective treatments for patients hospitalised with COVID-19,” said Levi Garraway, M.D., If approved, Actemra/RoActemra would be the first U.S. Roche also partnered with Gilead Sciences, Inc.,

Treatment 52

Treatment FDA Approval Clinical Trials FDA 52

The Pharma Data

AUGUST 27, 2020

The company has already tested the treatment on 10 adults between the ages of 56-70, and 10 over 71. Earlier this month, the US Government announced that it would purchase 100 million doses of the Moderna vaccine in a deal worth $1.53 The US has itself invested $955 million into the treatment’s development.

Vaccine 90

Vaccine Immune Response Clinical Trials Virus 90

The Pharma Data

OCTOBER 22, 2020

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. FOSTER CITY, Calif.–(BUSINESS –(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc.

FDA Approval 52

FDA Approval Treatment FDA Hospitals 52

The Pharma Data

NOVEMBER 27, 2020

FDA Approves Danyelza (naxitamab-gqgk) for the Treatment of Neuroblastoma. the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that the U.S. NEW YORK, Nov.

FDA Approval 52

FDA Approval Treatment FDA Clinical Trials 52

The Pharma Data

MARCH 27, 2021

Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use of Saxenda ® is expanded for the treatment of obesity in adolescents aged 12–17 years. If approved, Saxenda ® will be the first EU-approved treatment for obesity in adolescents.

Treatment 52

Treatment Therapies Trials Disease 52

The Pharma Data

SEPTEMBER 7, 2020

‘I just want my life back’ The government moved away from community testing on 12 March, instead only testing those admitted to hospital. The government is simply not doing enough with the existing medical expertise. However, many of these people may not have been tested for Covid. ” Person-centred rehab.

Doctors 52

Doctors Treatment Hospitals Government 52

ASPET

OCTOBER 12, 2023

The focus of the CET RAIDR effort is to bridge treatment gaps between threat identification and the implementation of licensed targeted MCMs, thereby strengthening warfighter resiliency. Responsible and relevant care must be more responsive to needs of expansive and novel threats, as showcased by lessons learned from the COVID-19 pandemic.

Therapies 100

Therapies Licensing Licensing FDA Approval 100

Agency IQ

MARCH 1, 2024

Explainer: What a government shutdown would mean for the FDA (Updated) With Congress again debating the passage of appropriations legislation, the FDA is facing a potential shutdown of operations as of Midnight on March 1. What is a government shut down? If none of the 12 bills are completed, then all government operations shut down.

Government 40

Government FDA Biosimilars Regulations 40

Conversations in Drug Development Trends

AUGUST 10, 2023

As one of the more recent fields to emerge in the clinical space, psychedelics have gained significant traction as a potential treatment for various neuropsychiatric diseases. Psychedelic Research at Worldwide Since 2017, Worldwide Clinical Trials have supported a myriad of sponsors leading the way in psychedelic research programs.

Science 98

Science Clinical Trials Trials Clinical Research 98

Drug Target Review

SEPTEMBER 21, 2023

The findings supported the possibility put forward by Cotton et al (2016) concerning the chance of repurposing these drugs for adulticidal treatment. The available treatment for that is minor surgery -to remove the nodules. With accessible and effective treatments, this is feasible. volvulus. doi: 10.1002/14651858.CD011146.pub2.

Drugs 106

Drugs Treatment Disease Research 106

The Pharma Data

JANUARY 17, 2021

a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced dose administration for the first patient in a Phase 2a clinical study of the company’s lead drug candidate, STP705, for the treatment of cutaneous basal cell carcinoma. GAITHERSBURG, Md.

Treatment 52

Treatment Trials FDA Approval RNA 52

Broad Institute

NOVEMBER 2, 2023

The research is guided by joint project and governance teams. Established in 2013, the Bayer-Broad collaboration is uniquely structured to encourage close coordination and ongoing, face-to-face interactions between researchers at both organizations.

Therapies 105

Therapies Research Small Molecule Clinical Trials 105

The Pharma Data

DECEMBER 11, 2020

On 1 December 2020, the Government of Norway and WHO met virtually for their annual strategic dialogue. WHO is deeply grateful to the Government of Norway for its leadership and pioneer work, acting as an example during the pandemic.”.

Disease 52

Disease Government Treatment 52

SCIENMAG: Medicine & Health

AUGUST 8, 2023

DALLAS, August 8, 2023 — As part of a focused effort to assess current cardiovascular treatment algorithms for racial bias, the American Heart Association,­ the single largest non-government supporter of heart and brain health research in the U.S., is funding three new scientific research projects at $50,000 each.

Research 60

Research Government Treatment 60

The Pharma Data

OCTOBER 25, 2020

for the treatment of severe vernal keratoconjunctivitis (VKC) in patients ages 4-18. “We look forward to working with the FDA during the review process and are optimistic this treatment could provide much needed symptom relief for those affected so they may better engage in their daily activities.”

Treatment 52

Treatment FDA Pharmaceuticals Clinical Trials 52

Common Sense for Drug Policy Blog

OCTOBER 1, 2024

New regulations governing methadone treatment for opioid use disorder go into effect in the US on October 2, 2024. As reported by the Associated Press on Sept. 20, 2024 ("US will let more people take methadone at home"):

Regulations 52

Regulations Government Treatment 52

KIF1A

JULY 29, 2023

Next week we’re overjoyed to convene families, clinicians, and researchers to discuss progress and goals in our mission to find treatments and cures of KAND. As this shift takes place in academia, industry, and government, it will be more important than ever for patient communities to advocate for resources and systems that serve them.

RNA 98

RNA Clinical Trials Disease Science 98

The Pharma Data

JANUARY 26, 2021

Food and Drug Administration’s Office of Orphan Products Development has granted Orphan Drug Designation to Uttroside-B , a small molecule chemotherapeutic for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. (OTCQB: QBIO), announced today that the U.S. . Source link.

FDA 40

FDA Treatment Small Molecule Drugs 40

Fierce BioTech

JULY 25, 2023

How combining datasets from multiple sources can inform and improve commercial strategies Hundreds of rare disease treatments have entered the market over the past decade—thanks largely to a combination of government incentives, strong urging from patient advocacy groups and advances in cell and gene therapies.

Pharma Companies 52

Pharma Companies Government Therapies Disease 52

The Pharma Data

AUGUST 11, 2020

The treatment is already available on an emergency basis for people suffering with severe symptoms from coronavirus. government and health care authorities around the globe to address the treatment needs of patients with COVID-19. Photo by FDA/CDC. The drug would go under the brand name of Veklury.

FDA Approval 52

FDA Approval FDA Government Virus 52

The Pharma Data

AUGUST 24, 2020

Currently, the FDA guidelines state that the treatment can be given to patients experiencing severe symptoms from coronavirus. This study involved 600 patients and was published in the Journal of the American Medical Association ; the improvement shown by patients on a remsdesivir treatment was that some required less supplemental oxygen.

FDA 52

FDA Government Clinical Research Hospitals 52